Faecal Immunochemical Test (FIT) Service

The NHS Birmingham and Solihull Integrated Care Board has progressed through the procurement process for the provision of a Faecal Immunochemical Testing (FIT) Service aimed at reducing bowel cancer mortality. This announcement marks the intention to award the contract to Bowel Cancer Screening Midlands and North West, who received the highest combined score in the selection criteria, encompassing quality, innovation, value, and social factors. The procurement process adheres to the Health Care Services (Provider Selection Regime) Regulations 2023, and not the Public Contracts Regulations 2015.

The competitive open procedure culminates with the awarding decision as of 20th May 2025, with a contract start date planned for 1st July 2025, subject to standstill period concluding on 2nd June 2025. The total anticipated contract value stands at £2,547,420, with services to be delivered in the Birmingham and Solihull region under CPV classification 85145000 for medical laboratory services. This tender presents a valuable opportunity for businesses involved in medical laboratory services, especially those specialising in innovative cancer screening methods, to engage with the NHS sector.

Companies skilled in enhancing service integration, fostering collaboration, and contributing to health equity could find this contract beneficial for business growth and public health impact. The procurement encourages participation from experienced suppliers capable of meeting the service requirements effectively from the outset, with a projected operational start in July 2025. The expected two-year contract duration, with a possible two-year extension, offers sustainable business potential in a critical health service area, emphasizing quality delivery and strategic collaboration to achieve long-term health outcomes.